Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Blog

Depression Woman warming up for a morning workout outdoors showing the benefits of exercise for depression
January 9, 2026in Depression 0 Comments 0 Likes

Benefits of Exercise for Depression: On Movement, Esketamine, and TMS

Depression remains one of the most common and disabling conditions worldwide. Researchers and clinicians increasingly recognize that recovery from Depression is not “one-size-fits-all.” For some, talk therapy and medication provide

by Dr. Bryan Bruno, Medical Director
Resources Man using Spravato to demonstrate the Spravato experience in his doctor's office
December 23, 2025in Resources 0 Comments 0 Likes

Understanding the Spravato Experience: Real Patient Results from the STRIVE Study

Depression is one of the most common mental health conditions in the world. While many people find relief through standard treatments such as oral antidepressants and psychotherapy, a significant number

by Dr. Bryan Bruno, Medical Director
Depression Woman using Spravato after the spravato monotherapy approval
December 12, 2025in Depression 0 Comments 0 Likes

Breakthrough Spravato Monotherapy Approval for Treatment-Resistant Depression

For many people living with Depression, the path to relief is not straightforward. Traditional antidepressants like SSRIs and SNRIs help millions, but some patients don’t respond at all, even after

by Dr. Bryan Bruno, Medical Director
Depression Pharmacist discusses low antidepressant success rates with a patient
November 18, 2025in Depression 0 Comments 0 Likes

Combatting a Low Rate of Long-Term Antidepressant Success with TMS Therapy

For decades, antidepressant medications have been the first-line treatment for major depressive disorder (MDD). While they have helped millions of people, the reality is that they often fall short—with new

by Dr. Bryan Bruno, Medical Director
Depression Happy patient takes spravato after learning how it can help him recover from Depression in the spravato medication guide
November 11, 2025in Depression 0 Comments 0 Likes

Your Spravato Medication Guide: An In-Depth Review for New York City Patients

In New York City, the fast pace and constant pressure can exacerbate Depression—especially for those who’ve tried multiple antidepressants with limited success. That’s why we’ve built out a Spravato medication

by Dr. Bryan Bruno, Medical Director
anxiety Man uses esketamine for anxiety with comorbid depression
November 11, 2025in anxiety 0 Comments 0 Likes

New Hope for NYC: Esketamine for Anxiety and Comorbid Treatment-Resistant Depression

Depression is widespread—and even more so in high-stress environments like New York City. Despite advances in treatment, many patients—especially those contending with treatment-resistant Depression (TRD) and comorbid anxiety–find that standard

by Dr. Bryan Bruno, Medical Director
Depression A person raising nasal spray to demonstrate the efficacy of Spravato for NYC patients
October 2, 2025in Depression 0 Comments 0 Likes

Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression

When Depression Doesn’t Respond—Hope Still Exists with the Spravato Treatment NYC Citizens Need If you’ve been living in New York City and struggling with Depression that just won’t lift, even

by Dr. Bryan Bruno, Medical Director
Depression A hand holding a glass of water and medication pills in palm without knowing the paradoxical effect of antidepressants
September 4, 2025in Depression 0 Comments 0 Likes

Understanding the Paradoxical Effect of Antidepressants

Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges. In recent years, however, researchers have continued to question conventional wisdom by

by Dr. Bryan Bruno, Medical Director
Depression A young doctor sharing information about symptoms of Depression in older adults from his digital tablet with an older patient
September 3, 2025in Depression 0 Comments 0 Likes

Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults

For many older adults, Depression is more than just sadness. It can be persistent, debilitating, and resistant to standard treatment. In fact, a significant number of adults over the age

by Dr. Bryan Bruno, Medical Director
Depression Hands in blue surgical gloves holding Ozempic Insulin injection pen, usually for diabetics but new research suggests we may use Ozempic for mental health
September 2, 2025in Depression 0 Comments 0 Likes

Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs

GLP-1 medications like Ozempic and Wegovy show promise in treating Depression, addiction, and cognitive issues. But what are GLP-1 drugs exactly, how do they work, what promise and results have

by Dr. Bryan Bruno, Medical Director
Prev

Posts navigation

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 22
Next

Recent Posts

  • An Update on Finding Depression Relief With TMS
  • Effects of Exercise on Depression: What New Research Means—and Where TMS Fits In
  • Understanding Esketamine vs Ketamine for Treatment-Resistant Depression in 2026
  • How Does Lithium Help Depression?
  • Finding the Best SNRI: A Pharmacological Comparison

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • Support
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}